EDGAR Filing Documents for 0001415889-14-002500

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001415889-14-002500

Filing Date

2014-08-14

Accepted

2014-08-14 16:06:57

Documents

Period of Report

2014-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	echo10q_june302014.htm	10-Q	648210
2	THIRD AMENDMENT TO THE CONSULTING AGREEMENT BY AND BETWEEN THE COMPANY AND ROBER	ex10-1.htm	EX-10.1	11941
3	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE	ex31-1.htm	EX-31.1	11986
4	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE	ex31-2.htm	EX-31.2	11609
5	CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-1.htm	EX-32.1	5242
6	CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1	ex32-2.htm	EX-32.2	4989
	Complete submission text file	0001415889-14-002500.txt		4412325

Data Files

Seq	Document	Type	Size
7	ecte-20140630.xml	EX-101.INS	490511
8	ecte-20140630.xsd	EX-101.SCH	67278
9	ecte-20140630_cal.xml	EX-101.CAL	46436
10	ecte-20140630_def.xml	EX-101.DEF	123090
11	ecte-20140630_lab.xml	EX-101.LAB	423208
12	ecte-20140630_pre.xml	EX-101.PRE	245034

Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103

Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)